Get a weekly digest of the latest psychedelic research, new studies, and platform updates delivered to your inbox.
No spam, ever. Unsubscribe anytime.
MAPS protocol for PTSD: 3 MDMA sessions with intensive therapeutic integration over 12 weeks.
Specifically developed for the treatment of PTSD. MDMA acts as an empathogen/entactogen, producing a state of increased emotional openness, reduced fear response, and enhanced trust. The MAPS protocol uses a male-female therapist pair approach across 3 medicine sessions with 3 integration sessions between each.
Serotonin, dopamine, and norepinephrine release. Oxytocin release. Amygdala activity reduction. Enhanced fear extinction and emotional processing.